Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study

Increasing severity of AD dementia in France is associated with increased use of resources as well as increased total societal and patient costs; informal care was the greatest cost contributor. Clinically meaningful cognitive decline is associated with significantly increased costs.